The Deal
Friday, July 25, 
12:44 pm


Recently in Biotech/Pharma Category
[Posted on September 11, 2007 - 12:35 PM]
Hewlett-Packard Co. is stepping up its drive to license technology to companies outside its core computer and printer businesses, such as healthcare. In the latest deal, Irish medical device maker Crospon Ltd. is licensing HP's inkjet printing technology to develop a drug delivery patch. Terms were not disclosed. HP has been licensing technology to companies outside its core computer...

Continue Reading



[Posted on September 5, 2007 - 1:16 PM]
Overlooked in the Labor Day exodus was the news Friday from across the pond that the Sandoz division of drug giant Novartis AG got the green light from European regulators to sell generic epoetin alfa, or EPO, the red blood cell booster used to treat anemia in cancer and kidney disease patients. It's another twist in one of the most...

Continue Reading



[Posted on August 23, 2007 - 4:51 PM]
In one of the biggest VC deals of the year, Globus Medical Inc. raised $110 million in venture funding led by Clarus Ventures. This is the fifth and largest round of funding raised by the four-year-old company, which develops a variety of spine implants, and had sales of $82 million last year. The medical device maker plans to use the money...

Continue Reading



[Posted on August 22, 2007 - 12:29 PM]
Researchers at the University of Texas at Austin have come up with a simple-to-use and cheap device that can detect cancerous cells while a patient waits in the doctor's office. Currently the device tests for oral cancer cells but could likely be adapted to detect cervical cancer cells as well. The device is made of acrylic and contains a...

Continue Reading



[Posted on August 17, 2007 - 4:21 PM]
Boston Scientific Corp. is floating another balloon, but not the kind doctors use to help insert one of the company's stents in a diseased artery. The medical devices giant is staggering under a $9 billion debt load, and it needs to find cash to pay it down. It doesn't help that sales of its flagship product, the drug-eluting stent,...

Continue Reading



[Posted on August 15, 2007 - 4:57 PM]
After market closed Wednesday, Amgen announced it is cutting 12% to 14% of its staff, or 2,200 to 2,600 jobs, as part of a restructuring. The biotech company also reduced its 2007 adjusted earnings forecast to a range of $4.13 to $4.23 a share from its earlier view of $4.28 a share. The company admitted recently it must cut costs...

Continue Reading



[Posted on July 19, 2007 - 3:15 PM]
The San Diego Union-Tribune reports Thursday that Pfizer Inc. has signed up the first tenant for its incubator — a research space on its campus in the San Diego suburb of La Jolla. The tenant, a professor at the nearby Scripps Institute, will be working on antibody technology with a two-year ride courtesy of Pfizer. The idea behind the...

Continue Reading



[Posted on July 19, 2007 - 11:30 AM]
Tech Confidential often covers biopharmaceutical license deals — also known as collaborations, partnerships or arrangements — that come together with much fanfare and promises of multimillion-dollar payments that, in fact, will likely never come to pass. Such deals are the lifeblood of small biotechs that can afford to develop a drug only so far and then sell the rights to...

Continue Reading



[Posted on July 10, 2007 - 5:22 PM]
Who says incubators are dead? Long-time surviving incubator Safeguard Scientifics Inc., technically a holding company that builds technology and life sciences startups, said Tuesday that one of its companies, Pittsburgh-based Cellumen Inc., has raised $8.7 million in Series B funding, American Venture Magazine and the Pittsburgh Business Times reported. Safeguard provided $6 million of the financing for Cellumen, a...

Continue Reading



[Posted on July 3, 2007 - 2:43 PM]
Biopharmaceutical company Diatos SA, a maker of anticancer drugs, announced Tuesday it has raised €9.4 million ($12.8 million) in a Series D funding round. Existing investors, including GIMV and Biotech Fund Flanders, both of Belgium; Credit Agricole Private Equity, Sofinnova Partners and Innoven Partenaires, all of France; and InterWest Partners of the U.S., led the round. Other participating investors included...

Continue Reading
Search


The Tech Confidential Network
The Tech Confidential Network unites the leading voices from around the Internet on the topics of high-tech startups, venture capital and investment exits. Bloggers and publishers that want to expand their readership and monetize their content are encouraged to apply to join the Tech Confidential Network.


Video

Episode 11, Behind the Money: Rob Kalin, Etsy Inc.

marynrob.gif
Rob Kalin stepped aside as CEO of Etsy Inc. on Tuesday. We first met him last November, when he shared the story of his online crafts marketplace.
 



Windward Ho!

Startups In New York




Syndicate


Fast Search


Categories
Monthly Archives

©Copyright 2008, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.